Bayesian Capital Management, LP
Position in ORGO — Organogenesis Holdings Inc.
CIK 1632551
Brooklyn, NY
Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,235
-$63,693 QoQ
Shares Held
14,500
-36.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#88
of 135 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bayesian Capital Management, LP holds $516,331 across 2 Drug Manufacturers - Specialty & Generic names. ORGO ranks #2 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,200 | $481,096 | |
| 2 | ORGO |
Organogenesis Holdings Inc.
This page
|
14,500 | $35,235 |
All Filings in ORGO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,235 | 14,500 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $98,928 | 22,900 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $29,635 | 10,584 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,206 | 10,284 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $65,783 | 16,084 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $304,038 | 39,900 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||